Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel... von Kantelhardt, Eva J, Vetter, Martina, Schmidt, Marcus, Veyret, Corinne, Augustin, Doris, Hanf, Volker, Meisner, Christoph, Paepke, Daniela, Schmitt, Manfred, Sweep, Fred, von Minckwitz, Gunter, Martin, Pierre-Marie, Jaenicke, Fritz, Thomssen, Christoph, Harbeck, Nadia

Volltext

Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: r... von Eichler, Martin, Singer, Susanne, Janni, Wolfgang, Harbeck, Nadia, Rack, Brigitte, Augustin, Doris, Wischnik, Arthur, Kiechle, Marion, Ettl, Johannes, Scholz, Christoph, Fink, Visnja, Schwentner, Lukas

Volltext

Quadratic modules in R[[X]] von AUGUSTIN, DORIS, KNEBUSCH, MANFRED

Volltext

ABC3 Consensus: Assessment by a German Group of Experts von Thomssen, Christoph, Augustin, Doris, Ettl, Johannes, Haidinger, Renate, Lück, Hans-Joachim, Lüftner, Diana, Marmé, Frederik, Marschner, Norbert, Müller, Lothar, Overkamp, Friedrich, Ruckhäberle, Eugen, Thill, Marc, Untch, Michael, Wuerstlein, Rachel, Harbeck, Nadia

Volltext

Prospective multi-center study for quantification of chemotherapies and CTX-related direct medication costs avoided by use of biomarkers uPA and PAI-1 in primary breast cancer von Jacobs, Volker R, Augustin, Doris, Wischnik, Arthur, Kiechle, Marion, Höss, Cornelia, Steinkohl, Oliver, Rack, Brigitte, Kapitza, Thomas, Krase, Peter

Volltext

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West Germa... von Nitz, Ulrike, Gluz, Oleg, Christgen, Matthias, Kates, Ronald E., Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Lorenz-Salehi, Fatemeh, Krabisch, Petra, Just, Marianne, Augustin, Doris, Liedtke, Cornelia, Chao, Calvin, Shak, Steven, Wuerstlein, Rachel, Kreipe, Hans H., Harbeck, Nadia

Volltext

De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker... von Harbeck, Nadia, Gluz, Oleg, Christgen, Matthias, Kates, Ronald Ernest, Braun, Michael, Küemmel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Kraemer, Stefan, Kleine-Tebbe, Anke, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, von Schumann, Raquel, Liedtke, Cornelia, Grischke, Eva-Maria, Schumacher, Johannes, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Nitz, Ulrike Anneliese

Volltext

The Membership Problem for finitely generated quadratic modules in the univariate case von Augustin, Doris

Volltext

Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer von Christgen, Matthias, Gluz, Oleg, Harbeck, Nadia, Kates, Ronald E., Raap, Mieke, Christgen, Henriette, Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Krabisch, Petra, Just, Marianne, Augustin, Doris, Graeser, Monika, Baehner, Frederick, Wuerstlein, Rachel, Nitz, Ulrike, Kreipe, Hans

Volltext

De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–... von Nitz, Ulrike, Gluz, Oleg, Graeser, Monika, Christgen, Matthias, Kuemmel, Sherko, Grischke, Eva-Maria, Braun, Michael, Augustin, Doris, Potenberg, Jochem, Krauss, Katja, Schumacher, Claudia, Forstbauer, Helmut, Reimer, Toralf, Stefek, Andrea, Fischer, Hans Holger, Pelz, Enrico, zu Eulenburg, Christine, Kates, Ronald, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Harbeck, Nadia, von Schumann, Raquel, Kuhn, Walther, Polata, Silke, Bielecki, Wojciech, Meyer, Ralf, Just, Marianne, Kraudelt, Susanne, Siggelkow, Wulf, Wortelmann, Heidi, Kleine-Tebbe, Anke, Leitzen, Lena, Kirchhof, Heidrun, Krabisch, Petra, Hackmann, John, Depenbusch, Reinhard, Gnauert, Karsten, Staib, Peter, Lehnert, Antje, Hoffmann, Oliver, Briest, Susanne, Lindner, Christoph, Heyl, Volker, Bauer, Leila, Uleer, Christoph, Mohrmann, Svjetlana, Viehstaedt, Nicole, Malter, Wolfram, Link, Theresa, Buendgen, Nana, Tio, Joke

Volltext

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial von Graeser, Monika, Gluz, Oleg, Biehl, Claudia, Ulbrich-Gebauer, Daniel, Christgen, Matthias, Palatty, Jenci, Kuemmel, Sherko, Grischke, Eva-Maria, Augustin, Doris, Braun, Michael, Potenberg, Jochem, Wuerstlein, Rachel, Krauss, Katja, Schumacher, Claudia, Forstbauer, Helmut, Reimer, Toralf, Stefek, Andrea, Fischer, Hans Holger, Pelz, Enrico, Zu Eulenburg, Christine, Kates, Ronald, Ni, Hua, Kolberg-Liedtke, Cornelia, Feuerhake, Friedrich, Kreipe, Hans Heinrich, Nitz, Ulrike, Harbeck, Nadia

Volltext

Abstract P4-10-05: Predictive value of HER2 expression, early response and tumor infiltrating lymphocytes (TILs) on efficacy of de-escalated pertuzumab+trastuzumab in the neoadjuva... von Gluz, Oleg, Kolberg-Liedtke, Cornelia, Biehl, Claudia, Christgen, Matthias, Kuemmel, Sherko, Grischke, Eva-Maria, Augustin, Doris, Braun, Michael, Potenberg, Jochem, Graeser, Monika, Kates, Ronald, Wuerstlein, Rachel, Feuerhake, Friedrich, Nitz, Ulrike, Kreipe, Hans, Harbeck, Nadia, Group, West German Study

Volltext

Abstract P4-17-06: Treatment strategies in male breast cancer: Results of a prospective multicenter study von Eggemann, Holm, Brucker, Cosima, Schirrmeister, Susen, Ringsdorf, Uta, Augustin, Doris, Schrauder, Michael, Thill, Marc, Flock, Felix, Kraudelt, Susanne, Gad, Gabriele, Kleine-Tebbe, Anke, Reinisch, Mattea, Dan Costa, Serban, Ignatov, Atanas

Volltext

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study von Harbeck, Nadia, Saupe, Steffen, Jäger, Elke, Schmidt, Marcus, Kreienberg, Rolf, Müller, Lothar, Otremba, Burkhard Joerg, Waldenmaier, Dirk, Dorn, Julia, Warm, Mathias, Scholz, Michael, Untch, Michael, de Wit, Maike, Barinoff, Jana, Lück, Hans-Joachim, Harter, Philipp, Augustin, Doris, Harnett, Paul, Beckmann, Matthias W., Al-Batran, Salah-Eddin

Volltext

The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial von Leinert, Elena, Singer, Susanne, Janni, Wolfgang, Harbeck, Nadia, Weissenbacher, Tobias, Rack, Brigitte, Augustin, Doris, Wischnik, Arthur, Kiechle, Marion, Ettl, Johannes, Fink, Visnja, Schwentner, Lukas, Eichler, Martin

Volltext

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer von Harbeck, Nadia, von Schumann, Raquel, Kates, Ronald Ernest, Braun, Michael, Kuemmel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Malter, Wolfram, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, Grischke, Eva-Maria, Biehl, Claudia, Liedtke, Cornelia, De Haas, Sanne Lysbet, Deurloo, Regula, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Gluz, Oleg

Volltext

Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised pha... von Nitz, Ulrike, Gluz, Oleg, Christgen, Matthias, Kates, Ronald E., Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Lorenz-Salehi, Fatemeh, Krabisch, Petra, Just, Marianne, Augustin, Doris, Liedtke, Cornelia, Chao, Calvin, Shak, Steven, Wuerstlein, Rachel, Kreipe, Hans H., Harbeck, Nadia

Volltext

Impact of PIK3CA mutation status on immune marker response and pCR in the WSG-ADAPT HER2+/HR+ phase II trial von Harbeck, Nadia, Nitz, Ulrike, Christgen, Matthias, Kates, Ronald E., Braun, Michael Wilhelm, Kummel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Malter, Wolfram, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, Kleine-Tebbe, Anke, Liedtke, Cornelia, de Haas, Sanne, Deurloo, Regula, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Gluz, Oleg

Volltext

International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts von Thomssen, Christoph, Lüftner, Diana, Untch, Michael, Haidinger, Renate, Würstlein, Rachel, Harbeck, Nadia, Augustin, Doris, Briest, Susanne, Ettl, Johannes, Fasching, Peter A., Förster, Frank, Kurbacher, Christian M., Lück, Hans-Joachim, Marschner, Norbert, Müller, Lothar, Müller, Volkmar, Perlova-Griff, Lidia, Radke, Isabel, Ruckhäberle, Eugen, Scheffen, Iris, Schumacher-Wulf, Eva, Schwoerer, Moritz, Steinfeld-Birg, Dieter, Ziegler-Löhr, Katja

Volltext

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group von Thomssen, Christoph, Vetter, Martina, Kantelhardt, Eva J, Meisner, Christoph, Schmidt, Marcus, Martin, Pierre M, Clatot, Florian, Augustin, Doris, Hanf, Volker, Paepke, Daniela, Meinerz, Wolfgang, Hoffmann, Gerald, Wiest, Wolfgang, Sweep, Fred C G J, Schmitt, Manfred, Jänicke, Fritz, Loibl, Sibylle, Minckwitz, Gunter von, Harbeck, Nadia

Volltext